{"podcast":{"title":"Breast Cancer Update","slug":"breast-cancer-update-757579","podcast_index_feed_id":757579,"rss_url":"https://feeds.captivate.fm/breast-oncology/","website_url":"https://www.researchtopractice.com/browse-by-tumor-types/breast-cancer","image_url":"https://artwork.captivate.fm/ad97e2be-455a-4b53-ab3d-383838c145e5/cbjJP3tyd5NWFP4W5DD1CnhC.png","author":"Dr. Neil Love","episode_count":100,"summary":"Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.","last_synced_at":"2026-06-12T06:20:52.628605+00:00","page_url":"https://stenobird.com/podcast/breast-cancer-update-757579"},"episode":{"title":"HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders","slug":"hr-positive-metastatic-breast-cancer-an-interview-with-dr-erika-hamilton-on-the-potential-role-of-protac-estrogen-receptor-degraders","published_at":"2025-11-20T19:59:00+00:00","page_url":"https://stenobird.com/podcast/breast-cancer-update-757579/hr-positive-metastatic-breast-cancer-an-interview-with-dr-erika-hamilton-on-the-potential-role-of-protac-estrogen-receptor-degraders","show_page_url":"https://stenobird.com/podcast/breast-cancer-update-757579","url":"https://breast-oncology.captivate.fm/episode/5625-hrposmbcprotac25","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/df424f80-9dc1-4792-82bb-e3c06c4c3bf9.mp3","summary":"Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, reviews available clinical data with PROTAC estrogen receptor degraders and their potential role in the management of HR-positive metastatic breast cancer. CME information and select publications here .","meta_description":"Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, reviews available clinical data with PROTAC estrogen receptor degraders an…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3516,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/hr-positive-metastatic-breast-cancer-an-interview-with-dr-erika-hamilton-on-the-potential-role-of-protac-estrogen-receptor-degraders/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/breast-cancer-update-757579/hr-positive-metastatic-breast-cancer-an-interview-with-dr-erika-hamilton-on-the-potential-role-of-protac-estrogen-receptor-degraders.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}